Association of serum s-adenosylmethionine, s-adenosylhomocysteine, and their ratio with the risk of dementia and death in a community
Authors:
Open Access
- 20 July 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Abstract
We examined the association of serum s-adenosylmethionine (SAM), s-adenosylhomocysteine (SAH) (methionine metabolites), and their ratio on the risk of dementia and death in a community-dwelling population of older Japanese individuals. 1371 residents of Hisayama, Japan, aged 65 years or older and without dementia, were followed for a median of 10.2 years (2007–2017). We divided serum SAM, SAH, and SAM/SAH ratio into quartiles. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and their 95% confidence intervals (CIs) of serum SAM, SAH, and SAM/SAH ratio levels on the risk of a composite outcome of all-cause dementia or death, and each outcome. During the follow-up, 635 participants developed all-cause dementia and/or died, of which 379 participants developed dementia and 394 deaths occurred. The multivariable-adjusted HRs of the composite outcome decreased significantly with increasing serum SAM levels (Pfor trend = 0.01), while they increased significantly with higher serum SAH levels (Pfor trend = 0.03). Higher serum SAM/SAH ratio levels were significantly associated with a lower risk of the composite outcome (Pfor trend = 0.002), as well as with lower risk of each outcome. Our findings suggest that the balance of methionine metabolites may closely associate with the risk of dementia and death.Keywords
Funding Information
- The Ministry of Education, Culture, Sports, Science and Technology of Japan (JP21H02100, JP19K07890, JP20K10503, JP20K11020, JP21K07522, JP21K11725, JP21K10448, JP18K17925, JP21H02100, JP19K07890, JP20K10503, JP20K11020, JP21K07522, JP21K11725, JP21K10448, JP18K17925, JP21H02100, JP19K07890, JP20K10503, JP20K11020, JP21K07522, JP21K11725, JP21K10448, JP18K17925, JP21H02100, JP19K07890, JP20K10503, JP20K11020, JP21K07522, JP21K11725, JP21K10448, JP18K17925)
- Fukuoka Prefecture and Kurume City in Japan (Fukuoka BioCluster Project Grants)
- the Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan (JPMH20FA1002)
- the Japan Agency for Medical Research and Development (JP21dk0207053)
This publication has 40 references indexed in Scilit:
- Increased plasma S-adenosyl-homocysteine levels induce the proliferation and migration of VSMCs through an oxidative stress-ERK1/2 pathway in apoE−/− miceCardiovascular Research, 2012
- DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models☆☆☆The Journal of Nutritional Biochemistry, 2011
- Clinicopathological Outline of Dementia with Lewy Bodies Applying the Revised Criteria: The Hisayama StudyBrain Pathology, 2008
- Methionine flux to transsulfuration is enhanced in the long living Ames dwarf mouseMechanisms of Ageing and Development, 2006
- S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid productionMolecular and Cellular Neuroscience, 2005
- Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease?FEBS Letters, 2003
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- S-AdenosylmethionineThe International Journal of Biochemistry & Cell Biology, 2000
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975